Medicina Legal, Psiquiatría y Patología
Departamento
National Cancer Center Hospital
Kashiwa, JapónPublicaciones en colaboración con investigadores/as de National Cancer Center Hospital (10)
2024
-
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists
Histopathology, Vol. 84, Núm. 3, pp. 429-439
2022
-
NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma
Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805
-
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1335-1354
2021
-
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC
Journal of Thoracic Oncology, Vol. 16, Núm. 4, pp. 686-696
2020
-
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 10, pp. 1599-1610
-
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
Journal of Thoracic Oncology, Vol. 15, Núm. 5, pp. 709-740
-
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 4, pp. 499-519
-
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424
2019
-
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 377-407
2017
-
Programmed death-ligand 1 immunohistochemistry testing: A review of analytical assays and clinical implementation in non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 35, Núm. 34, pp. 3867-3876